|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| OTC Analgesics in Germany |
|
|
|
|
€ 198,00 |
Editeur
: |
Euromonitor |
Langue
: |
Anglais |
Date de publication : |
Juillet 2002 |
Taille du document : |
15 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 40 pages | Septembre 2002 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,rheumatoid arthritis,arthritis,...,...
|
| Research
focus: |
demand analysis,consumer trends,market outlook, |
| Geographic
focus: |
usa,united kingdom,denmark |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Drug Delivery Outlook 2001
176 pages | Juillet 2001 |
In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery.
Subseque |
955,00 €
|
| |
| |
The Pharmaceutical Distribution Outlook 1998-2008
165 pages | Octobre 1998 |
Industry growth and consolidation means that pharmaceutical manufacturers are no longer geographically limited in their operations and now market their products globally, creating a vast commercia |
795,00 €
|
| |
| |
The Pharmacogenomics Outlook
174 pages | Août 2000 |
Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development.
By identifying differenc |
955,00 €
|
| |
| |
The Diagnostics Outlook to 2005
130 pages | Février 1999 |
Diagnostic market : The current in vitro diagnostic (IVD) market is discussed, identifying how the market can be segmented according to country, end user, clinical speciality and disease area.
795,00 €
|
|
| |
| |
The CNS Outlook 1998-2010
201 pages | Août 1999 |
In 1998, the CNS market expanded by 12.8%, growing in value from $29.4bn in 1997 to almost $33bn in 1998.
Expansion is being driven by the introduction of new technologies and products which are ra |
795,00 €
|
| |
| |
Maximising the Drug Lifecycle
102 pages | Août 2001 |
Up to $100bn of the 2000 pharmaceutical market, including blockbuster drugs with combined sales of $34bn will be exposed to generic competition by 2005.Maximising The Drug Lifecycle provides a detaile |
955,00 €
|
| |
| |
The CNS Outlook 2000
203 pages | Octobre 2000 |
The Central Nervous System (CNS) market has shown sustained growth in 1999 with the expansion continuing to be driven by several factors.A greater understanding of the neuropharmacological mechanisms |
955,00 €
|
| |
| |
European Pharmaceutical Industry
35 pages | Juillet 2002 |
The Pharmaceutical industry remains one of Europe’s best performing sectors (employment, R&D and trade surplus).
The world pharmaceutical market was worth an estimated € 392,640 million (at ex-fact |
600,00 €
|
| |
| |
Chinese Markets for Pharmaceuticals
225 pages | Janvier 2002 |
China's demand for pharmaceuticals has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic |
2 835,00 €
|
| |
| |
Strategic Intelligence: The Top 12 Pharmaceutical Companies
158 pages | Novembre 2001 |
The pressure on the pharmaceutical company R&D has never been greater.
It is estimated that $100 billion worth of products will face patent expiry by 2005.
Of this, $37 billion represe |
1 021,89 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Analgesics in Germany |
|
|
The German market for OTC analgesics growth not so rapidly and reached a value of Euro 772 million (US$ 729 million) in 2001, an increase of 1.6% on the previous year. Over the review period, the market increased by Euro 66 million, representing an overall increase of more than 9.3%. This report is part of Euromonitor’s highly successful Major Market Profiles series. These briefings provide concise, up-to-date, accurate and affordable analysis of 156 commercial, industrial and service sectors in France, Germany, the UK and the US.
|
|
Market Size
Market Sectors
Marketing Activity
Corporate Overview
Distribution
Consumer Profile
Market Forecasts
Sector Forecasts
|
|
|
PPLSEN
|
|
|
|
|
